Midsized Biotech Alliance Of America (mbaa) lobbies on its own behalf. For Q3 2026 it reported $300K across 1 client report and lists 1 lobbyist across its filings. Issues include Medicare/Medicaid and Pharmacy.
| Client | Reported | Issues |
|---|---|---|
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | $300K | Medicare/Medicaid, Pharmacy |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $300K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.